New molecular mechanisms to explain the neuroprotective effects of Insulin-like Growth Factor II in a cellular model of Parkinson's Disease.

[1]  S. K. Suthar,et al.  Truncation or proteolysis of α-synuclein in Parkinsonism , 2023, Ageing Research Reviews.

[2]  Ashok Kumar,et al.  Molecular Chaperones’ Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis , 2023, Cells.

[3]  C. Alberini.  IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases , 2023, Trends in Neurosciences.

[4]  Lydia W. S. Finley,et al.  Regulation and function of the mammalian tricarboxylic acid cycle , 2022, The Journal of biological chemistry.

[5]  R. Requejo-Aguilar.  Cdk5 and aberrant cell cycle activation at the core of neurodegeneration , 2022, Neural regeneration research.

[6]  O. Shirihai,et al.  Mitochondrial signal transduction , 2022, Cell metabolism.

[7]  J. Westermarck,et al.  Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling , 2022, Neurotherapeutics.

[8]  Denisse Sepúlveda,et al.  Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease , 2022, Scientific Reports.

[9]  A. Rivera,et al.  Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons , 2021, Antioxidants.

[10]  Zaaima Al-Jabri,et al.  Proteomics: Concepts and applications in human medicine , 2021, World journal of biological chemistry.

[11]  J. Cook,et al.  Efficiency and equity in origin licensing to ensure complete DNA replication. , 2021, Biochemical Society transactions.

[12]  E. Martín-Montañez,et al.  Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease , 2021, Redox biology.

[13]  S. S. Margolis,et al.  The proteasome and its role in the nervous system. , 2021, Cell chemical biology.

[14]  N. Bal,et al.  Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer—Its Comparative Expression, Processing and Signaling in Mammalian CNS , 2021, International journal of molecular sciences.

[15]  Hong Jiang,et al.  Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown , 2021, Cell Death & Disease.

[16]  C. Hetz,et al.  Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein , 2021, Neural regeneration research.

[17]  M. García-Fernández,et al.  Relationship Between Mitochondrial Structure and Bioenergetics in Pseudoxanthoma elasticum Dermal Fibroblasts , 2020, Frontiers in Cell and Developmental Biology.

[18]  A. Messina,et al.  High-Resolution Respirometry Reveals MPP+ Mitochondrial Toxicity Mechanism in a Cellular Model of Parkinson’s Disease , 2020, International journal of molecular sciences.

[19]  M. Girardis,et al.  Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia , 2020, EMBO molecular medicine.

[20]  S. Graham,et al.  Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development , 2020, Aging and disease.

[21]  J. Jankovic,et al.  Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  L. Ellerby,et al.  Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates , 2020, bioRxiv.

[23]  C. Martínez-Cué,et al.  Cellular Senescence in Neurodegenerative Diseases , 2020, Frontiers in Cellular Neuroscience.

[24]  N. Chandel,et al.  Mitochondrial TCA cycle metabolites control physiology and disease , 2020, Nature Communications.

[25]  S. Grieco,et al.  Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review , 2019, Neuroscience Research.

[26]  J. Kapfhammer,et al.  RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury , 2019, Nature Communications.

[27]  Xianlin Han,et al.  Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers , 2019, JAMA network open.

[28]  P. Musich,et al.  Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure , 2019, CNS neuroscience & therapeutics.

[29]  S. Berman,et al.  Potential Role of Mic60/Mitofilin in Parkinson’s Disease , 2019, Front. Neurosci..

[30]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[31]  F. Kaya,et al.  Mitochondrial inner membrane protein (mitofilin) knockdown induces cell death by apoptosis via an AIF-PARP-dependent mechanism and cell cycle arrest. , 2018, American journal of physiology. Cell physiology.

[32]  David M. Smith,et al.  A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers , 2018, Nature Communications.

[33]  Xinnan Wang,et al.  PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions. , 2018, Molecular cell.

[34]  Sarah A. Stern,et al.  Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice , 2017, The Journal of Neuroscience.

[35]  K. Nagata,et al.  Dnmt1-dependent Chk1 pathway suppression is protective against neuron division , 2017, Development.

[36]  C. Pedraza,et al.  IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids , 2017, Redox biology.

[37]  S. Kar,et al.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases , 2017, Molecular Neurobiology.

[38]  O. Tysnes,et al.  Epidemiology of Parkinson’s disease , 2017, Journal of Neural Transmission.

[39]  A. Massie,et al.  The Proteasome Inhibition Model of Parkinson’s Disease , 2016, Journal of Parkinson's disease.

[40]  M. Beal,et al.  Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease , 2016, The Journal of Neuroscience.

[41]  A. Dinkova-Kostova,et al.  Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function , 2016, Biological chemistry.

[42]  A. Dinkova-Kostova,et al.  The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.

[43]  I. Sandovici,et al.  Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis , 2015, Nature Communications.

[44]  S. Levison,et al.  Insulin and IGF receptor signalling in neural-stem-cell homeostasis , 2015, Nature Reviews Endocrinology.

[45]  J. Frade,et al.  Neuronal cell cycle: the neuron itself and its circumstances , 2015, Cell cycle.

[46]  H. Werner,et al.  Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects , 2014, European Neuropsychopharmacology.

[47]  Tao Wang,et al.  Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models , 2014, PloS one.

[48]  C. Alberini,et al.  Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice , 2014, EMBO molecular medicine.

[49]  E. Martín-Montañez,et al.  Involvement of IGF-II receptors in the antioxidant and neuroprotective effects of IGF-II on adult cortical neuronal cultures. , 2014, Biochimica et biophysica acta.

[50]  J. Blusztajn,et al.  IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice , 2014, PloS one.

[51]  Sarah A. Stern,et al.  Enhancement of Memories by Systemic Administration of Insulin-Like Growth Factor II , 2014, Neuropsychopharmacology.

[52]  Youwei Zhang,et al.  Roles of Chk1 in cell biology and cancer therapy , 2014, International journal of cancer.

[53]  T. Iwamoto,et al.  Reduced Adult Hippocampal Neurogenesis and Working Memory Deficits in the Dgcr8-Deficient Mouse Model of 22q11.2 Deletion-Associated Schizophrenia Can Be Rescued by IGF2 , 2013, The Journal of Neuroscience.

[54]  Jianhua Zhang,et al.  Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death , 2012, PloS one.

[55]  I. Castilla-Cortázar,et al.  Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats , 2011, Journal of Translational Medicine.

[56]  I. Castilla-Cortázar,et al.  Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats , 2011, Journal of Translational Medicine.

[57]  M. Brand,et al.  Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.

[58]  S. Blain,et al.  Chk1 has an essential role in the survival of differentiated cortical neurons in the absence of DNA damage , 2011, Apoptosis.

[59]  S. Blain,et al.  S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons. , 2010, Brain : a journal of neurology.

[60]  J. Jordán,et al.  Effects of MPP+ on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells. , 2010, Pharmacological research.

[61]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[62]  A. Brunati,et al.  Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase , 2007, FEBS letters.

[63]  R. Quirion,et al.  Molecular basis of programmed cell death involved in neurodegeneration , 2005, Trends in Neurosciences.

[64]  Li Li,et al.  The mitochondrial inner membrane protein mitofilin controls cristae morphology. , 2005, Molecular biology of the cell.

[65]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[66]  J. Adams,et al.  The proteasome: structure, function, and role in the cell. , 2003, Cancer treatment reviews.

[67]  S. Kar,et al.  Insulin‐like growth factor‐II/mannose‐6‐phosphate receptor: Widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype , 2003, The Journal of comparative neurology.

[68]  S. Ackerman,et al.  Oxidative stress, cell cycle, and neurodegeneration. , 2003, The Journal of clinical investigation.

[69]  Y. A. Minamishima,et al.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.

[70]  T. Joh,et al.  Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos , 1999, The Journal of Neuroscience.

[71]  F. González-Sastre,et al.  Assay of succinate dehydrogenase activity by a colorimetric-continuous method using iodonitrotetrazolium chloride as electron acceptor. , 1993, Analytical biochemistry.

[72]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[73]  J. Bopassa,et al.  Parkin interacts with Mitofilin to increase dopaminergic neuron death in response to Parkinson's disease-related stressors. , 2020, American journal of translational research.

[74]  S. Chu,et al.  Measurement of Oxidative Stress: Mitochondrial Function Using the Seahorse System. , 2018, Methods in molecular biology.

[75]  N. Jha,et al.  Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die? , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[76]  Zhentao Zhang,et al.  DNA polymerase-β is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons , 2009, Apoptosis.